No Data
No Data
10-Q: Q2 2024 Earnings Report
10-K/A: Annual report (Amendment)
10-Q/A: Quarterly report (Amendment)
Express News | Coeptis Therapeutics- Unaudited Condensed Consolidated Financial Statements for Sept 30, 2023, in Co's Form 10-Q/a May No Longer Be Relied Upon
Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Express News | Coeptis Therapeutics Closes on $4.3 Million of Series a Preferred Offering
No Data